OCRA is the voice for the ovarian cancer community.
OCRA advocates on Capitol Hill to improve research and education, drug and diagnostic safety, and access to quality care for all members of the ovarian and gynecologic cancer community. To date, OCRA has helped secure more than $3.8 billion in federal funding.
Chad Ramsey, OCRA’s Vice President of Policy, writes a monthly update with behind-the-scenes reports to keep you current on the latest news from our Advocate Leaders and policy team.
Now that I can, I’m traveling again and one of my goals this year is to advocate for ovarian cancer [research] because I finally have the chance.
From sending messages to your representatives to becoming an OCRA Advocate Leader and traveling to Capitol Hill, there are myriad ways to support the cause.
Sign up for our Action Alert mailing list so that you can stay up to date on our latest advocacy activities.
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance Federal Update As of this writing, Congress has failed to come to an agreement on funding for the current fiscal year and the federal government is in a shutdown. We are closely monitoring the impact that the shutdown is having on the patient community and … Continued
OCRA joined more than 400 patient advocates, providers and researchers at the Rally for Medical Research Hill Day on September 18th to call on Congress to increase critical funding at the National Institutes of Health (NIH) for Fiscal Year 2026. Dozens of organizations, including the event’s founding organizer American Association for Cancer Research, met with … Continued
On September 16, 2025, OCRA’s Vice President of Policy, Chad Ramsey, spoke at the Denmark Embassy in Washington, DC, about how international collaboration and cross-sector partnerships can advance research progress and improve patient outcomes. Ramsey joined Congresswoman Bonnie Watson Coleman in sharing insights with key stakeholders in the gynecologic cancer space at this event hosted … Continued
Get email updates about research news, action alerts, and ways to join the fight.
